̽��ֱ��

̽��ֱ��grants, from the Research England Development (RED) Fund, will support two new programmes: TenU and a new Policy Evidence Unit for ̽��ֱ�� Commercialisation and Innovation (UCI), which will be based at Cambridge’s Institute for Manufacturing (IfM).

TenU will bring together the heads of technology transfer offices (TTOs) from ten of the world’s leading universities to share expertise and experience to develop, improve, and disseminate best practice in research commercialisation. UCI will undertake research to create the evidence base for informing research commercialisation policy for government and universities. ̽��ֱ��two groups will work closely in areas of mutual interest.

Research from the TenU universities has led to world-changing innovations such as rapid whole-genome sequencing, the page rank algorithm technology that became the basis for Google, the world’s first artificial vaccine against viral hepatitis B, fibre optics, one of the most widely used medications for HIV treatment, and programmed T cell therapies.

As countries work��to rebuild their��economies in the wake of COVID-19, university TTOs will play a critical role in turning early-stage, research-based innovations into new products and services across different sectors. In the UK, the Industrial Strategy has identified universities as key drivers of innovation.

“We welcome this vital support from Research England, which enables us to continue to share, compare, and advance international best practice in university research commercialisation for the benefit of our economies and societies locally, nationally, and globally,” said Tony Raven, CEO of Cambridge Enterprise, the ̽��ֱ�� of Cambridge’s commercialisation arm.

Apart from Cambridge, the other members of TenU are Columbia, Edinburgh, Imperial College London, Leuven, Manchester, MIT, Stanford, Oxford, and ̽��ֱ�� College London.

̽��ֱ��Policy Evidence Unit for ̽��ֱ�� Commercialisation and Innovation (UCI), based at Cambridge’s Institute for Manufacturing, will help to drive a step change in universities’ contributions to delivering increased R&D and innovation in the UK.

̽��ֱ��new unit will be developed in partnership with the Centre for Science, Technology and Innovation Policy (CSTI) and the National Centre for Universities and Business (NCUB). It will support the needs of government departments, funding agencies, and universities for better data, evidence, and expert insights, to develop more effective approaches for university commercialisation and innovation.

̽��ֱ��needs for better evidence are growing as we move from the immediate COVID-19 crisis into the longer-term economic recovery period, and as the government looks to maximise the value realised from its investment in the research base. Universities need to find new ways of working with businesses, investors and others to open up opportunities, address emerging innovation challenges, and improve productivity. To unlock this potential, governments will have to adapt policies and funding programmes to become key enabling partners in this process.

Working closely with key stakeholders, UCI will initially focus on three areas:

• Developing an evidence base on how the COVID-19 induced economic crisis is affecting universities’ abilities to contribute to innovation and identify possible actions to ensure they are able to play a strategic and active role in the national economic recovery.
• Improving our understanding of the research-to-innovation commercialisation journeys and examine how policies and university practices could be strengthened to deliver increased value to the UK.
• Advancing the data and metrics available to better capture the performance of universities in delivering economic and social impacts through their commercialisation activities to facilitate more effective benchmarking and evaluation of performance.

Tomas Ulrichsen, Director of the new Policy Evidence Unit for ̽��ֱ�� Commercialisation and Innovation, said: “I am delighted to bring expertise from CSTI, the ̽��ֱ�� of Cambridge, and NCUB together to establish this important new policy evidence unit. ̽��ֱ��grant from the Research England Development Fund will enable us to support policymakers, funders, and universities with better and more targeted evidence and expert insight, to consider how to build on and adapt their approaches to university-driven commercialisation and innovation. This will help economies across the UK recover, reconfigure, and thrive through the economic recovery following the COVID-19 pandemic.”

“In line with the UK Government’s R&D Roadmap, Research England as part of UK Research and Innovation needs to demonstrate we are world class at securing economic and social benefits from research,” said David Sweeney, Executive Chair of Research England. “ ̽��ֱ�� technology transfer is at the heart of that. Research England funding for TenU will help showcase best practice at the global cutting edge, with the new UCI policy unit providing critical evidence and metrics. We look forward to deepening these international links.”